Authors: Chen Lulu, Chen Youxin DOI: 10.3760/cma.j.issn.2095-0160.2020.01.012 Published 2020-01-10 Cite as Chin J Exp Ophthalmol, 2020,38(01): 60-63. Abstract [View PDF] [Read Full Text] Retinal vein occlusion(RVO) is the second common retinal vascular disease after diabetic retinopathy.The Management of Retinal Vein Occlusion-Consensus Document published […]
Category: 2020, No. 01
Neuroprotective effect of vascular endothelial growth factor
Authors: Tang Jia, Chen Youxin DOI: 10.3760/cma.j.issn.2095-0160.2020.01.013 Published 2020-01-10 Cite as Chin J Exp Ophthalmol, 2020,38(01): 64-67. Abstract [View PDF] [Read Full Text] Vascular endothelial growth factor(VEGF), also known as vascular permeability factor, can promote the proliferation and migration of vascular endothelial cells, and enhance vascular […]
Effects of complement dysfunction on diabetic retinopathy
Authors:Liao Yi, Chen Hua DOI: 10.3760/cma.j.issn.2095-0160.2020.01.014 Published 2020-01-10 Cite as Chin J Exp Ophthalmol, 2020,38(01): 68-72. Abstract [View PDF] [Read Full Text] Diabetic retinopathy (DR) is one of the common neuronal and microvascular complications of diabetes, and it is the key cause […]
Anti-apoptotic mechanism of heme oxygenase 1 and its protective role in related ophthalmopathy
Authors: Chen Weiqi, Hong Yu DOI: 10.3760/cma.j.issn.2095-0160.2020.01.015 Published 2020-01-10 Cite as Chin J Exp Ophthalmol, 2020,38(01): 73-76. Abstract [View PDF] [Read Full Text] Heme oxygenase 1 (HO-1) is a stress response protein, and its anti-apoptosis research becomes a new hot spot.In recent years, HO-1 plays an […]
Treatment on retinopathy of prematurity
Authors: Fang Siwen, Ma Xiang DOI: 10.3760/cma.j.issn.2095-0160.2020.01.016 Published 2020-01-10 Cite as Chin J Exp Ophthalmol, 2020,38(01): 77-80. Abstract [View PDF] [Read Full Text] Retinopathy of prematurity (ROP) as a leading cause of blindness in children in both developed and developing countries, is […]